MedPath

Skin Irritation Test of Ten Products

Not Applicable
Conditions
Dermatitic Reaction of Face
Interventions
Other: ten products (S01~S10) and two blank (BK1, BK2)
Registration Number
NCT05245383
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Evaluation of cutaneous tolerance of ten products by primary irritant patch test

Detailed Description

The purpose of this clinical study was the evaluation of skin irritation potential of ten products after a single application under occlusive patch on human skin.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 20 to 70 years old, healthy male and female (sex ratio 1:1)
  • No acute or chronic diseases including skin diseases.
  • No current medications.
Read More
Exclusion Criteria
  • Pregnancy or breast feeding.
  • Abnormal blood test result/results (evaluation criteria: WBC, AST, ALT, and Creatinine)
  • Back skin with moles, acne, tattoo, scars, red spots, burns, etc.
  • Current dermatology medication which might affect skin condition evaluation.
  • Current irritated reaction on test site.
  • Participating in other clinical trial(s) within 7 days.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Single armten products (S01~S10) and two blank (BK1, BK2)-
Primary Outcome Measures
NameTimeMethod
Safety/Adverse Event Outcome MeasureUp to 48 hours

Number of participants with Serous and Non-Serous Adverse Event

Total Number of Positive Responses Across All ParticipantsReading results at 30 minutes, 24 hours and 48 hours after the removal of the test products.

Change from baseline of test products by using ICDRG (International Contact Dermatitis Research Group) grading

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath